false
0001410428
0001410428
2024-11-14
2024-11-14
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(D) of the Securities
Exchange Act Of 1934
Date of report (Date of earliest event reported):
November 14, 2024
XWELL,
Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| 001-34785 |
|
20-4988129 |
| (Commission File Number) |
|
(IRS Employer Identification No.) |
| 254 West 31st Street, 11th Floor, New York, New York |
|
10001 |
| (Address of Principal Executive Offices) |
|
(Zip Code) |
(212) 750-9595
(Registrant’s Telephone Number, Including
Area Code)
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.01 per share |
|
XWEL |
|
The Nasdaq Stock Market |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 2.02 | Results of Operations
and Financial Condition. |
On November 14, 2024, XWELL, Inc. (the “Company”)
issued a press release announcing its financial results for the quarter ended September 30, 2024, and provided a corporate update. A copy
of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
In accordance with General Instruction B.2 of
Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, that is furnished pursuant to this Item 2.02 shall
not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration
statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set
forth by specific reference in such filing.
Forward-Looking Statements
The press release includes forward-looking statements,
which may be identified by words such as “believes,” “expects,” “anticipates,” “estimates,”
“projects,” “intends,” “should,” “seeks,” “future,” “continue,”
or the negative of such terms, or other comparable terminology. Forward-looking statements are statements that are not historical facts.
Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from the
forward-looking statements contained herein. The forward-looking statements in the press release constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. There are a number of important factors that could cause actual
results or events to differ materially from those indicated by such forward-looking statements, including, but not limited to, the risks
and uncertainties and other factors discussed from time to time in the Company’s filings with the Securities and Exchange Commission
(“SEC”), including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form
8-K and proxy statements, registration statement and other documents filed by the Company from time to time with the SEC. The Company
expressly disclaims any obligation to publicly update any forward-looking statements contained herein, whether as a result of new information,
future events or otherwise, except as required by law.
| Item 9.01 |
Financial Statements and Exhibits. |
(d) Exhibits
* This exhibit is furnished pursuant to Item 2.02 and shall not be
deemed to be “filed.”
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
XWELL,
Inc. |
| |
|
|
| Date: November 14, 2024 |
By: |
/s/ Ezra T. Ernst |
| |
Name: |
Ezra T. Ernst |
| |
Title: |
President and Chief Executive Officer |
Exhibit 99.1
XWELL, Inc. Reports Third Quarter
2024 Results
NEW YORK, November 14, 2024 -- XWELL, Inc. (Nasdaq:
XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results
for the third quarter and nine-month period ended September 30, 2024.
Recent Highlights:
| · | XWELL delivered 2024 third quarter revenue growth of approximately 13% from the comparable quarter in
2023. Additionally, for the nine-month period ended September 30, 2024, XWELL delivered revenue growth of approximately 16% from the comparable
nine-month period in 2023. |
| | | |
| · | XWELL continues to focus on reducing its cost structure and returning to profitability. For the nine-month
period ended September 30, 2024, the Company: |
| | | |
| o | Reduced cost of sales by approximately 6% when compared with the comparable nine-month period in 2023. |
| | | |
| o | Reduced general and administrative expenses by approximately 5% when compared with the comparable nine-month
period in 2023. |
| | | |
| o | Reduced total operating expenses by approximately 35% when compared with the comparable nine-month period
in 2023. |
| | | |
| · | In August of 2024, XWELL continued to fuel its future growth plans by executing a registered direct offering
resulting in gross proceeds of $1.4 million, which was priced at a premium to market. |
“We're pleased with our third quarter and
year-to-date performance, marked by the successful implementation of growth and productivity initiatives across our organization,”
said Ezra Ernst, CEO of XWELL. “As we focus on achieving healthy, sustainable growth and returning to profitability, we're seeing
considerable opportunities across all of our brands. Looking forward, we believe we're well-positioned for a strong 2025, and we remain
confident that our consistent strategy execution will benefit our customers, partners, employees, and shareholders.”
XWELL, Inc. Reports Third Quarter 2024 Results
Page 2
Travel Wellness Portfolio - XpresSpa®
XpresSpa is the leading airport retailer of wellness
services and related products. As of September 30, 2024, there were 19 domestic XpresSpa locations and 10 international locations operating,
including two XpresSpa locations in Dubai International Airport in the United Arab Emirates, one XpresSpa location in Zayad International
Airport in Abu Dhabi, United Arab Emirates, three XpresSpa locations in Schiphol Amsterdam Airport in the Netherlands and four XpresSpa
locations in the Istanbul Airport in Turkey.
As previously announced, XpresSpa opened a new
location in Philadelphia International Airport (PHL) during the 2024 second quarter. Located in Terminal B near Gate B2, the PHL XpresSpa
includes the Company’s new branding as well as innovative offerings including its new Ceragem therapeutic massage and compression
beds, Clockwork MiNiCURE and Human Touch automated massages.
Out-of-Airport Wellness Portfolio - Naples Wax Center®
XWELL’s first off-airport brand, Naples
Wax Center, is a group of upscale hair removal and aesthetic services boutiques with three locations in Florida. Acquired in mid-September
2023, Naples Wax Center provides core products and service including face and body waxing as well as a range of skincare and cosmetic
products from its current three locations.
The Company is in the process of executing additional
leases in Florida, forecasting approximately 10 XWELL out-of-airport locations in 2025.
New York City’s Penn Station XpresSpa
Consistent with XWELL’s strategy to extend
its footprint into transportation hubs, the Company is executing plans to open an XpresSpa location in New York City’s Penn Station
in 2025.
The labor-lite, tech-forward spa will serve commuters,
neighborhood locals, and tourists with wellness-focused retail, autonomous massage, and nail care services, enabling seamless and efficient
experiences for time-crunched New York City travelers.
Life Sciences & Biosurveillance -- XpresCheck®
and HyperPointe™
The Company’s XpresTest, Inc. subsidiary
(“XpresCheck”), in collaboration with the Centers for Disease Control and Prevention (“CDC”) and Ginkgo Bioworks
(NYSE: DNA), currently operates 7 biosurveillance stations in 6 of the nation’s busiest airports.
XWELL, Inc. Reports Third Quarter 2024 Results
Page 3
XpresTest, Inc. began conducting bio surveillance
monitoring with the Centers for Disease Control and Prevention (CDC) in collaboration with Concentric by Ginkgo BioWorks in 2021. The
CDC's Traveler-based Genomic Surveillance (TGS) program is a flexible, multimodal platform that consists of complementary approaches of
sample collection from arriving international travelers at U.S. airports, including voluntary nasal swabbing, aircraft wastewater, air
monitoring and airport wastewater sampling to enhance early detection of new SARS-CoV-2 variants and other pathogens, and fill gaps in
global surveillance.
Additionally, the Company began reporting operating
results for HyperPointe within its XpresCheck business. Beginning in June 2020, and following its acquisition by XWELL in January 2022,
HyperPointe’s management team and suite of services and technology have been utilized to develop and deploy the technological infrastructure
necessary to scale the growth of the XpresCheck business. HyperPointe’s experience in this space continues to play a critical role
in the expansion of ongoing biosurveillance efforts created in partnership with Ginkgo BioWorks and the CDC.
Liquidity and Financial Condition
As of September 30, 2024, the Company had approximately
$4.4 million of cash and cash equivalents (excluding restricted cash), approximately $11.7 million in marketable securities, total current
assets of approximately $19.5 million, and no long-term debt.
On August 8, 2024, the Company closed its registered
direct offering priced at a premium to market for the issuance and sale of an aggregate of 652,705 shares of its common stock, par value
$0.01 per share, at a purchase price of $2.18 per share. The gross proceeds to the Company from the offering were approximately $1.4 million,
before deducting offering expenses payable by the Company. The Company intends to use the net proceeds of this offering for working capital
and general corporate purposes.
XWELL, Inc. Reports Third Quarter 2024 Results
Page 4
Summary Third Quarter 2024 Financial Results
Revenue
Total revenue for the third quarter ended September
30, 2024, was $8.4 million, compared to $7.5 million for the 2023 third quarter.
Revenue for the 2024 third quarter primarily consisted
of approximately $4.9 million from XpresSpa locations and Treat locations and approximately $3.1 million from XpresTest, which includes
XWELL’s bio-surveillance partnership and its HyperPointe business. Naples Wax Center, which was acquired near the end of the 2023
third quarter, accounted for approximately $0.4 million.
Total Cost of Sales
Total cost of sales for the 2024 third quarter
was approximately $6.4 million, compared to approximately $6.4 million for the 2023 third quarter.
Salaries and Benefits; General and Administrative Expenses
Salaries and benefits were approximately $1.9
million, compared to $1.2 million for the 2023 third quarter. The 2023 third quarter included an approximate $1 million Employee Retention
Credit (“ERC”), reducing salaries and benefit expenses last year.
General and administrative expenses were approximately
$4.5 million, including over $2.0 million related to extraordinary legal expenses, compared to approximately $3.0 million for the 2023
third quarter.
Total Operating Expenses
Total operating expenses were approximately $6.8
million, compared to approximately $13.2 million for the 2023 third quarter.
Operating Loss
The operating loss was approximately $4.8 million,
compared with an operating loss of approximately $12.1 million for the 2023 third quarter.
XWELL, Inc. Reports Third Quarter 2024 Results
Page 5
Net Loss Attributable to XWELL
Net loss attributable to XWELL was approximately
$4.8 million, compared to approximately $11.5 million for the 2023 third quarter.
Webcast and Earnings
Conference Call
XWELL will host a webcast and conference call
at 5:00 pm Eastern Time today. We encourage investors and all interested parties to listen via webcast as there is a limited
capacity to access the conference call by dialing 1-412-317-6026.
The live and later archived webcast can be accessed
from the Investor Relations section of the Company’s website at http://xwell.com. Visitors to the website should select the
“Investors” tab and navigate to the “Events” link to access the webcast.
About XWELL, Inc.
XWELL, Inc. (Nasdaq: XWEL) is a leading global
wellness holding company operating multiple brands: XpresSpa®, Treat™, Naples Wax Center®, XpresCheck® and HyperPointe™.
| · | XpresSpa is a leading retailer of wellness services and related products. |
| · | Naples Wax Center is a group of upscale skin care boutiques. |
| · | XpresCheck, in partnership with the CDC and Concentric by Ginkgo, conducts biosurveillance monitoring
in its airport locations to identify new SARS-CoV-2 variants of interest and concern as well as other pathogens entering the country from
across the world. |
| · | HyperPointe is a leading digital healthcare and data analytics relationship company serving the global
healthcare industry. |
XWELL,
Inc. Reports Third Quarter 2024 Results
Page 6
Forward-Looking Statements
This press release may contain "forward-looking"
statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended. These include statements preceded by, followed by or that otherwise
include the words "believes," "expects," "anticipates," "estimates," "projects," "intends,"
"should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology.
Forward-looking statements relating to expectations about future results or events, including the Company’s current plans and expectations
relating to the business and operations and future store openings, including but not limited to, future openings of Naples Wax Center
and XpresSpa stores, are based upon information available to XWELL as of the date of this press release, and are not guarantees of the
future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information
concerning these and other risks is contained in the Company’s Annual Report on Form 10-K, as amended, Quarterly Reports on Form
10-Q and Current Reports on Form 8-K, and other Securities and Exchange Commission filings. All subsequent written and oral
forward-looking statements concerning XWELL, or other matters and attributable to XWELL or any person acting on its behalf are expressly
qualified in their entirety by the cautionary statements above. XWELL does not undertake any obligation to publicly update any of these
forward-looking statements to reflect events or circumstances that may arise after the date hereof.
Media
Maria Kucinski
MWW
mkucinski@mww.com
v3.24.3
Cover
|
Nov. 14, 2024 |
| Cover [Abstract] |
|
| Document Type |
8-K
|
| Amendment Flag |
false
|
| Document Period End Date |
Nov. 14, 2024
|
| Entity File Number |
001-34785
|
| Entity Registrant Name |
XWELL,
Inc.
|
| Entity Central Index Key |
0001410428
|
| Entity Tax Identification Number |
20-4988129
|
| Entity Incorporation, State or Country Code |
DE
|
| Entity Address, Address Line One |
254 West 31st Street
|
| Entity Address, Address Line Two |
11th Floor
|
| Entity Address, City or Town |
New York
|
| Entity Address, State or Province |
NY
|
| Entity Address, Postal Zip Code |
10001
|
| City Area Code |
212
|
| Local Phone Number |
750-9595
|
| Written Communications |
false
|
| Soliciting Material |
false
|
| Pre-commencement Tender Offer |
false
|
| Pre-commencement Issuer Tender Offer |
false
|
| Title of 12(b) Security |
Common Stock, par value $0.01 per share
|
| Trading Symbol |
XWEL
|
| Security Exchange Name |
NASDAQ
|
| Entity Emerging Growth Company |
false
|
| X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
| Name: |
dei_AmendmentFlag |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
| Name: |
dei_DocumentPeriodEndDate |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:dateItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
| Name: |
dei_DocumentType |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:submissionTypeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
| Name: |
dei_EntityAddressAddressLine1 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionAddress Line 2 such as Street or Suite number
| Name: |
dei_EntityAddressAddressLine2 |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- Definition
+ References
+ Details
| Name: |
dei_EntityAddressCityOrTown |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCode for the postal or zip code
| Name: |
dei_EntityAddressPostalZipCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the state or province.
| Name: |
dei_EntityAddressStateOrProvince |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:stateOrProvinceItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityCentralIndexKey |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:centralIndexKeyItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionIndicate if registrant meets the emerging growth company criteria. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityEmergingGrowthCompany |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
| Name: |
dei_EntityFileNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:fileNumberItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
| Name: |
dei_EntityIncorporationStateCountryCode |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarStateCountryItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityRegistrantName |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
| Name: |
dei_EntityTaxIdentificationNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:employerIdItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionLocal phone number for entity.
| Name: |
dei_LocalPhoneNumber |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:normalizedStringItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
| Name: |
dei_PreCommencementIssuerTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
| Name: |
dei_PreCommencementTenderOffer |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTitle of a 12(b) registered security. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
| Name: |
dei_Security12bTitle |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:securityTitleItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionName of the Exchange on which a security is registered. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
| Name: |
dei_SecurityExchangeName |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:edgarExchangeCodeItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Section 14a
-Number 240
-Subsection 12
| Name: |
dei_SolicitingMaterial |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
| Name: |
dei_TradingSymbol |
| Namespace Prefix: |
dei_ |
| Data Type: |
dei:tradingSymbolItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
| X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act. Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
| Name: |
dei_WrittenCommunications |
| Namespace Prefix: |
dei_ |
| Data Type: |
xbrli:booleanItemType |
| Balance Type: |
na |
| Period Type: |
duration |
|
XWELL (NASDAQ:XWEL)
過去 株価チャート
から 12 2024 まで 12 2024
XWELL (NASDAQ:XWEL)
過去 株価チャート
から 12 2023 まで 12 2024
